arrow
Back
A

Ahmet Bılıcı

i̇stanbul medipol university

26H-index
375Paper Count
3.8KCitation Count
Published Papers 55
Publication Date
Prognostic Significance and Clinical Implications of the New FIGO 2023 Staging System in Patients with Endometrial Cancer
err2026-08-16
err0
errOAAI
errHakan Özçelik; Nazan Demir; Melisa Eryaşar; Oğuz Çelebi; Erdem Sünger; Burçin Çakan Demirel; Jamshid Hamdard; Özgür Açıkgöz; Burak Giray; Doğan Vatansever; İsa Aykut Özdemir; Volkan Ülker; Çağatay Taşkıran; Fatih Selcukbiricik; Ahmet Bilici
errShare
errSave
Efficacy and Tolerability of Pazopanib in Elderly Patients with Advanced Soft Tissue Sarcoma: A Multicentre Real-World Study from Turkey
err2026-06-23
err0
errOAAI
errMehmet Mutlu Kidi; Harun Muğlu; Mustafa Karaağaç; Sinan Koca; Oguz Kara; Ahmet Bilici; Ertugrul Bayram
errShare
errSave
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study
errCancers
IF4.4
err2026-06-18
err0
errOAAI
errBahadır Köylü; Özde Melisa Celayir; Harun Muğlu; Orçun Can; Fatma Şen; Bala Başak Öven; Umut Demirci; Teoman Şakalar; Serdar Karakaya; Özlem Er; Ömer Burak Ekinci; Abdullah Sakin; Hasibe Bilge Gür; Yağmur Karaman; Duygu Ercan Uzundal; Esra Aşık; Kezban Nur Pilancı; Nilüfer Avcı; Pınar Gürsoy; Muhammet Ali Kaplan; Serkan Menekşe; Engin Kut; Erkan Arpacı; Hakan Kosku; Selami Bayram; Taha Koray Şahin; Emine Türkmen; Abdurrahman Aykut; Yeşim Ağyol; Ahmet Özveren; Elif Şahin; Öztürk Ateş; Gamze Serin Özel; Cevat İlteriş Kıkılı; Fatih Kemik; Başak Oyan; Taner Korkmaz; Osman Gökhan Demir; Deniz Tural; Şeyda Gündüz; Şahin Laçin; Nazan Demir; Didem Tunalı; Ahmet Bilici; Ömer Fatih Ölmez; İlhan Hacıbekiroğlu; Erdem Çubukçu; Ozan Yazıcı; Atila Yıldırım; Burak Bilgin; Mehmet Ali Nahit Şendur; Ali Murat Tatlı; Mustafa Özdoğan; Burak Yasin Aktaş; Metin Kanıtez; Bülent Karabulut; Ferhat Ekinci; Ertuğrul Bayram; Gamze Gököz Doğu; Saadettin Kılıçkap; Perran Fulden Yumuk; Nil Molinas Mandel; Fatih Selçukbiricik
errShare
errSave
A Novel Biological Index for Predicting Neoadjuvant Treatment Response in HER2-Positive Breast Cancer: The Tumor-Immune-Proliferation-Inflammation (TIPI) Score
err2026-04-19
err0
errOAAI
errErdem Sünger; Harun Muğlu; Mehmet Haluk Yücel; Ebru Engin Delipoyraz; Maral Martin Mıldanoğlu; Hakan Özçelik; Sena Fidan; Cihat Terzioğlu; Burçin Çakan Demirel; Jamshid Hamdard; Yasin Kutlu; Özgür Açıkgöz; Aslı Çakır; Mesut Şeker; Ahmet Bilici
errShare
errSave
Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCR
err2026-04-17
err0
errOAAI
errAyberk Bayramgil; Mehmet Haluk Yücel; Ezgi Turkoglu; Ali Kaan Guren; Fatih Kemik; Bedirhan Ulufer; Burçin Çakan Demirel; Anil Yildiz; Omer Sacli; Eda Ercin; Nazım Can Demircan; Oguzcan Kinikoglu; Sahin Lacin; Ahmet Bilici; Yunus Emre Altintas; Melike Ozcelik
errShare
errSave
Determinants of survival after neoadjuvant chemotherapy in resectable gastric cancer: adjuvant dose intensity, radiotherapy, and pathologic response
err2026-04-13
err0
PREAI
errÖzgecan Dülgar Kaya; Ayberk Bayramgil; Ahmet Bilici; Erdem Sünger; Tuğba Kaya; Tuğba Başoğlu Tüylü; Tuba Baydaş; Sinan Koca; Yeşim Ağyol; Selver Işık; Burçin Çakan Demirel; Vedat Buğra Erol; Nilufer Bulut; Busra Niğdelioğlu; Melike Özçelik
errShare
errSave
Survival Outcomes After irAE-Related Nivolumab Discontinuation in mNSCLC: A Multicenter Study
err2026-04-08
err0
errOAAI
errAysegul Merc Cetinkaya; Mehmet Haluk Yucel; Latif Karahan; Mustafa Ersoy; Ahmet Bilici; Mustafa Erman; Ali Murat Tatli; Sema Sezgin Goksu
errShare
errSave
Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy
err2026-04-07
err0
errOAAI
errMaral Martin Mıldanoğlu; Fatih Kemik; Melisa Eryaşar; Hakan Özçelik; Erdem Sünger; Mehmet Haluk Yücel; Ebru Engin Delipoyraz; Sena Fidan; Harun Muğlu; Burçin Çakan Demirel; Jamshid Hamdard; Yasin Kutlu; Özgür Açıkgöz; Fatih Selcukbiricik; Mesut Şeker; Ahmet Bilici
errShare
errSave
Immunotherapy Versus Chemo-Immunotherapy as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Real-World Retrospective Study
err2026-04-06
err0
errOAAI
errMaral Martin Mildanoglu; Mehmet Haluk Yucel; Ebru Engin Delipoyraz; Erdem Sunger; Hakan Ozcelik; Sena Fidan; Cihat Terzioglu; Harun Muglu; Jamshid Hamdard; Burcin Cakan Demirel; Yasin Kutlu; Ozgur Acikgoz; Mesut Seker; Ahmet Bilici
errShare
errSave
Prognostic Significance of Frailty in Liver Cirrhosis Patients: A Prospective Single-Center Study
err2026-03-04
err0
errOAAI
errMaral Martin Mıldanoğlu; Atilla Akpınar; Koray Koçhan; Ahmet Bilici; Elmas Biberci Keskin; Hakan Şentürk
errShare
errSave
Relationship Between Mast Cell Population of Microenvironment and Prognosis in Colorectal Cancer
err2026-03-03
err0
errOAAI
errNeşe Yeldir; Ebru Engin Delipoyraz; Aslı Çakır; Ahmet Bilici
errShare
errSave
Association of Post-Neoadjuvant Chemotherapy MRI and 18F-FDG PET/CT Findings with Tumor Response and Prognosis in Breast Cancer
err2026-02-28
err0
errOAAI
errBurçin Çakan Demirel; Semra Taş; Ayberk Bayramgil; Anıl Yıldız; Şahin Bedir; Nigar Erkoç; Aynur Özen; Merve Tokoçin; Nida Sünnetçi Arıkan; Ali Muhammedoğlu; Yunus Emre Altıntaş; Ahmet Bilici
errShare
errSave
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group
err2026-02-11
err0
PREAI
errSalih Tunbekici; Hamit Bal; Oguzcan Kınıkoglu; Hayati Arvas; Harun Muglu; Ahmet Bilici; Mustafa Seyyar; Halil Goksel Guzel; Banu Ozturk; Ozge Yalıcı; Duygu Ozaskın; Ramazan Cosar; Fatmagul Cıkladılmez; Evrican Zin; Aytac Terzi; Tugce Ulaslı; Taha Koray Sahın; Denız Can Guven; Gamze Serın; Merve Bıyıklı Alemdar; Bilgin Demir; Ali Kalem; Pervin Can; Kazım Uygun; Elif Sahin; Teoman Sakalar; Ali Kaan Guren; Gokhan Ozturk; Enes Yesılbas; Tugce Kubra Gunes; Burcu Belen; Muzaffer Ugraklı; Kursat Dıslı; Ahmet Oruc; Melek Karakurt Eryılmaz; Ismet Culcuoglu; Mustafa Ersoy; Bahadır Koylu; Fatih Selcukbiricik; Oguzhan Yıldız; Mehmet Emın Yılmaz; Saadettin Kılıckap; Ertugrul Bayram; Caner Acar; Gokhan Sahin; Haydar Cagatay Yuksel; Mustafa Murat Mıdık; Pınar Gursoy; Erdem Goker
errShare
errSave
Prognostic Value of Systemic Inflammatory Markers in Locally Advanced or Metastatic Melanoma: A Real-World Analysis
errCancers
IF4.4
err2026-01-28
err0
errOAAI
errBurçin Çakan Demirel; Semra Taş; Taliha Güçlü Kantar; Melek Özdemir; Tolga Doğan; Canan Karan; Burcu Yapar Taşköylü; Atike Gökçen Demiray; Serkan Değirmencioğlu; Ahmet Bilici; Gamze Gököz Doğu; Arzu Yaren
errShare
errSave
Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study
err2026-01-26
err0
errOAAI
errİlker Nihat Ökten; Tuba Baydaş; Mahmut Emre Yıldırım; Cemil Bilir; Şuayib Yalçın; Erdem Çubukçu; Eda Tanrıkulu Şimşek; Çağatay Aslan; Faysal Dane; Sinemis Çelik; Ahmet Bilici; Mehmet Ali Nahit Şendur; Bala Başak Öven; Abdurrahman Işıkdoğan; Hacı Mehmet Türk; Mustafa Karaca; Bülent Karabulut; Melike Özçelik; Mahmut Gümüş; Umut Kefeli; Nuri Karadurmuş
errShare
errSave
Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors-A Turkish Oncology Group Study
errCANCERS
IF4.4
err2025-12-29
err0
errOAAI
errEfil, Safa Can; Kus, Fatih; Koylu, Bahadir; Durukan, Bekir Mert; Bayram, Selami; Guzel, Halil Goksel; Ozturk, Banu; Muglu, Harun; Bilici, Ahmet; Kose, Fatih; Alan, Ozkan; Karapelit Agitoglu, Eda; Guner, Gurkan; Besen, Ali Ayberk; Helvaci, Kaan; Araz, Murat; Kacan, Turgut; Arslan, Cagatay; Unal, Ahmet; Eniseler, Emine Bihter; Biter, Sedat; Ekinci, Ferhat; Aslan, Ferit; Unek, Ilkay Tugba; Tas, Semra; Acar, Omer; Ates, Ozturk; Sakalar, Teoman; Akbas, Sinem; Karakas, Hilal; Akinci, Muhammed Bulent; Yalcin, Bulent; Yalcin, Suayip; Sendur, Mehmet Ali Nahit
errShare
errSave
Real-World Outcomes of Treatment Approaches and the Impact of Systemic Inflammation Markers on Survival in Patients with Locally Advanced and Metastatic Laryngeal Cancer
err2025-12-18
err0
errOAAI
errBurçin Çakan Demirel; Semra Taş; Taliha Güçlü Kantar; Melek Özdemir; Tolga Doğan; Canan Karan; Burcu Yapar Taşköylü; Atike Gökçen Demiray; Serkan Değirmencioğlu; Ahmet Bilici; Gamze Gököz Doğu; Arzu Yaren
errShare
errSave
Impact of oral nutritional support adherence on muscle strength, body composition, and general health status in gastrointestinal cancer patients: ONMUS study
err2025-12-01
err1
PREAI
errOzveren, Ahmet; Cil, Timucin; Bicakli, Derya Hopanci; Gultekin, Gamze; Dogan, Dilek; Zengin, Canan; Bilici, Ahmet; Sabir, Songul; Ercelep, Ozlem; Eksi, Feyzanur; Selcukbiricik, Fatih; Yilmaz, Meltem; Ergene, Gozde; Tatli, Ali Murat; Aksoy, Feray Karsli; Uysal, Ozen; Dizdar, Omer; Yildirim, Hasan Cagri; Ozmen, Nesrin; Ozturk, Seniz; Sanli, Ulus Ali; Karabulut, Bulent
errShare
errSave
Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study
err2025-12-01
err0
PREAI
errUysal, Mukremin; Saglam, Sezer; Beypinar, Ismail; Saglam, Esra Kaytan; Mammadov, Elkhan; Ocak, Birol; Aybi, Ozge; Arikan, Rukiye; Ergen, Sefika Arzu; Gursoy, Pinar; Sakin, Abdullah; Kaya, Vildan; Ozden, Ercan; Eren, Tulay; Demiray, Atike Gokcen; Oyman, Abdilkerim; Tatli, Ali Murat; Turk, Haci Mehmet; Gulmez, Ahmet; Demir, Atakan; Alan, Ozkan; Sakalar, Teoman; Sen, Erdem; Ucar, Gokhan; Kilickap, Saadettin; Bilici, Ahmet; Oksuz, Didem Colpan; Karabulut, Bulent
errShare
errSave
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study(vol61 , 638 , 2025)
err2025-11-07
err0
errOAAI
errKalkan, Ziya; Ebinc, Senar; Arcagok, Murat; Bilici, Ahmet; Yildiz, Ozcan; Kilickap, Saadettin; Guven, Deniz Can; Tatli, Ali Murat; Sumbul, Ahmet Taner; Mandel, Nil Molinas; Ozturk, Akin; Bardakci, Murat; Karakaya, Serdar; Kaplan, Muhammet Ali
errShare
errSave